The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

Amtagvi® and its accompanying design marks, Proleukin ®, Iovance ®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other ...

Gold is usually viewed as a safehaven asset and a store of wealth, but it has now shown its ability to replace platinum in ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge ...

In a new report, American Cancer Society (ACS) researchers discovered mixed progress in major cancer risk factors, preventive ...

A new study finds that Schistosoma haematobium infection, and its treatment, can activate cancer-related genes in the cervix, ...

For most screenable cancers, a pandemic-related surge of late-stage diagnoses in 2020 quickly returned to pre-pandemic levels in 2021, with the exception of cervical cancer.  According to the National ...

A parasitic worm may raise the risk of cervical cancer through several mechanisms, scientists have found, although HPV ...

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for unresectable or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.